Ørsted A/S
Ørsted A/S (DOGEF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Ørsted A/S (DOGEF), featuring income statements, balance sheets, and cash flow data.
Ørsted A/S (DOGEF) Income Statement & Financial Overview
Review Ørsted A/S DOGEF income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $17.68B | $13.16B | $12.44B | $15.56B |
Cost of Revenue | $10.44B | $8.20B | $13.94B | $9.41B |
Gross Profit | $7.24B | $4.96B | -$1.50B | $6.15B |
Gross Profit Ratio | $0.41 | $0.38 | -$0.12 | $0.40 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $3.34B | $3.44B |
Operating Expenses | $13.59B | -$1.76B | $880.00M | $1.15B |
Total Costs & Expenses | $24.03B | $6.44B | $13.94B | $10.56B |
Interest Income | $1.11B | $1.54B | $2.85B | $810.00M |
Interest Expense | $1.95B | $2.78B | $669.00M | $810.00M |
Depreciation & Amortization | $2.57B | $2.55B | $2.68B | $2.42B |
EBITDA | -$2.24B | $8.64B | $6.53B | $7.34B |
EBITDA Ratio | -$0.13 | $0.66 | $0.52 | $0.47 |
Operating Income | -$6.34B | $6.72B | -$1.50B | $7.49B |
Operating Income Ratio | -$0.36 | $0.51 | -$0.12 | $0.48 |
Other Income/Expenses (Net) | -$416.00M | -$1.18B | -$549.00M | -$1.39B |
Income Before Tax | -$6.76B | $5.53B | -$559.00M | $4.43B |
Income Before Tax Ratio | -$0.38 | $0.42 | -$0.04 | $0.29 |
Income Tax Expense | -$677.00M | $339.00M | $1.10B | $1.82B |
Net Income | -$6.16B | $5.05B | -$1.72B | $2.56B |
Net Income Ratio | -$0.35 | $0.38 | -$0.14 | $0.16 |
EPS | -$15.83 | $12.00 | -$4.09 | $5.70 |
Diluted EPS | -$15.81 | $12.00 | -$4.09 | $5.70 |
Weighted Avg Shares Outstanding | $420.23M | $421.25M | $420.23M | $419.47M |
Weighted Avg Shares Outstanding (Diluted) | $420.23M | $421.25M | $420.23M | $419.47M |
Over the last four quarters, Ørsted A/S achieved steady financial progress, growing revenue from $15.56B in Q1 2024 to $17.68B in Q4 2024. Gross profit stayed firm with margins at 41% in Q4 2024 versus 40% in Q1 2024. Operating income totaled -$6.34B in Q4 2024, maintaining a -36% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$2.24B. Net income dropped to -$6.16B, with EPS at -$15.83. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan